Singapore markets closed

Carmat (CXT.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
4.1850+0.0500 (+1.21%)
As of 09:17AM CET. Market open.
Full screen
Previous close4.1350
Bid4.0950 x N/A
Ask4.2550 x N/A
Day's range4.1400 - 4.1850
52-week range3.0200 - 9.8900
Avg. volume0
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    CARMAT Provides Update on the Renegotiation of the Repayment Terms of Its Loans With Its Financial Creditors

    PARIS, February 22, 2024--CARMAT provides update on the renegotiation of the repayment terms of its loans with its financial creditors

  • Business Wire

    CARMAT: 2024 Financial Calendar

    PARIS, February 05, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces its indicative financial calendar for 2024.

  • Reuters

    Artificial heart maker Carmat misses 2023 revenue target

    PARIS (Reuters) -French artificial heart maker Carmat reported full year revenue of 2.8 million euros ($3 million), missing its target after supply issues disrupted the company's production ramp-up, sending its shares down 6%. The company had warned in September that it would miss a target of full-year sales of between 10 million and 13 million euros after it reported first-half revenue of only 600,000 euros. Carmat, which survived a cash crunch in mid-October, said it would soon launch a capital increase, estimated to raise at least 50 million euros ($55 million), to ensure it had enough financing for the next 12 months.